Bellerophon Therapeutics, Inc.
(NASDAQ : BLPH)

( )
BLPH After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 1.11%446.361.0%$804.90m
MDTMedtronic Plc 2.53%118.190.6%$589.76m
ABTAbbott Laboratories 1.08%117.260.8%$518.80m
DHRDanaher Corp. 1.91%218.500.7%$470.31m
BSXBoston Scientific Corp. 4.22%39.531.0%$421.13m
ISRGIntuitive Surgical, Inc. 0.59%713.372.3%$391.71m
ALGNAlign Technology, Inc. 3.08%536.466.3%$350.50m
BDXBecton, Dickinson & Co. 2.36%246.561.0%$349.34m
SYKStryker Corp. 1.90%240.271.3%$311.59m
DXCMDexCom, Inc. 2.20%364.097.8%$290.56m
EYESSecond Sight Medical Products, Inc. 304.90%5.7917.7%$272.48m
IDXXIDEXX Laboratories, Inc. 2.85%499.703.8%$268.01m
BAXBaxter International, Inc. 2.21%78.111.8%$230.39m
ZBHZimmer Biomet Holdings, Inc. 1.37%158.391.7%$224.78m
AAgilent Technologies, Inc. 1.02%116.161.6%$216.12m

Company Profile

Bellerophon Therapeutics, Inc. focuses on developing products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline include PH-ILD, PH-COPD, and PH-Sarc. The company was founded in 2009 and is headquartered in Warren, NJ.